Farther Finance Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.79K | Sell |
494
-203
| -29% | -$3.61K | ﹤0.01% | 3131 |
|
|
2025
Q1 | $12.2K | Buy |
697
+443
| +174% | +$7.76K | ﹤0.01% | 2643 |
|
|
2024
Q4 | $7.57K | Buy |
254
+108
| +74% | +$3.22K | ﹤0.01% | 2486 |
|
|
2024
Q3 | $2.28K | Buy |
146
+17
| +13% | +$266 | ﹤0.01% | 2950 |
|
|
2024
Q2 | $2.24K | Buy |
129
+37
| +40% | +$642 | ﹤0.01% | 2750 |
|
|
2024
Q1 | $1.43K | Sell |
92
-264
| -74% | -$4.09K | ﹤0.01% | 2637 |
|
|
2023
Q4 | $5.32K | Buy |
356
+339
| +1,994% | +$5.06K | ﹤0.01% | 1942 |
|
|
2023
Q3 | $275 | Buy |
17
+13
| +325% | +$210 | ﹤0.01% | 2408 |
|
|
2023
Q2 | $166 | Buy |
+4
| New | +$166 | ﹤0.01% | 2385 |
|